BeiGene Valuation
| 688235 Stock | 181.38 5.38 3.06% |
At this time, the firm appears to be overvalued. BeiGene shows a prevailing Real Value of USD132.54 per share. The current price of the firm is USD181.38. Our model approximates the value of BeiGene from analyzing the firm fundamentals such as Current Valuation of 161.24 B, return on equity of -0.23, and Profit Margin of (0.26) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 10.0622 | Enterprise Value 161.2 B | Enterprise Value Ebitda (86.19) | Price Sales 6.9163 | Forward PE 526.3158 |
Overvalued
Today
Please note that BeiGene's price fluctuation is very steady at this time. Calculation of the real value of BeiGene is based on 3 months time horizon. Increasing BeiGene's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BeiGene is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BeiGene Stock. However, BeiGene's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 181.38 | Real 132.54 | Hype 114.75 | Naive 186.77 |
The real value of BeiGene Stock, also known as its intrinsic value, is the underlying worth of BeiGene Company, which is reflected in its stock price. It is based on BeiGene's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BeiGene's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BeiGene helps investors to forecast how BeiGene stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BeiGene more accurately as focusing exclusively on BeiGene's fundamentals will not take into account other important factors: BeiGene Cash |
|
BeiGene Total Value Analysis
BeiGene is presently forecasted to have takeover price of 161.24 B with market capitalization of 164.44 B, debt of 688.37 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BeiGene fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
161.24 B | 164.44 B | 688.37 M |
BeiGene Investor Information
About 33.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 4.57. BeiGene had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from BeiGene's historical financial statements, BeiGene is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.BeiGene Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BeiGene has an asset utilization ratio of 42.35 percent. This suggests that the Company is making USD0.42 for each dollar of assets. An increasing asset utilization means that BeiGene is more efficient with each dollar of assets it utilizes for everyday operations.BeiGene Ownership Allocation
BeiGene holds a total of 115.06 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BeiGene Profitability Analysis
The company reported the revenue of 2.46 B. Net Loss for the year was (881.71 M) with loss before overhead, payroll, taxes, and interest of (511.06 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BeiGene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BeiGene and how it compares across the competition.
About BeiGene Valuation
The stock valuation mechanism determines BeiGene's current worth on a weekly basis. Our valuation model uses a comparative analysis of BeiGene. We calculate exposure to BeiGene's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BeiGene's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 B | 2.2 B |
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |